News Events

News

Comac Medical presents newly available data of successfully completed clinical trials at AASLD The Liver Meeting

November 28, 2022

We are happy to share that Comac Medical has been assigned with conducting Phase 2 randomized, placebo-controlled GULLIVER-2 trial. The results of the study were presented at AASLD The Liver Meeting on 4th-8th November.
Check the results in the following document.

Share:

News

View All News
IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Read More
Comac Medical Announces Strategic Leadership Transition
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...
Read More
Bulgaria shortens approval timeline for clinical trials
The Bulgarian Drug Agency has announced reduced time periods for consideration of clinical trials on medicinal products for...
Read More
View All News